CUSIP: G6461G106
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
60,072,916
-
Share change
-
-1,420,652
-
Total reported value
-
$516,626,000
-
Price per share
-
$8.60
-
Number of holders
-
34
-
Value change
-
-$10,285,082
-
Number of buys
-
19
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP G6461G106?
CUSIP G6461G106 identifies NFH - NEW FRONTIER HEALTH CORP - ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP G6461G106:
Institutional Holders of NEW FRONTIER HEALTH CORP - ORD SHS (NFH) as of Q4 2020
As of 31 Dec 2020,
NEW FRONTIER HEALTH CORP - ORD SHS (NFH) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,072,916 shares.
The largest 10 holders included
Vivo Capital, LLC, Capital Research Global Investors, Fosun International Ltd, MORGAN STANLEY, Aspex Management (HK) Ltd, BAMCO INC /NY/, Capital International Investors, Yiheng Capital Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, and York Capital Management Global Advisors, LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.